179324-87-9,
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate,
(R)-BoroLeu-(+)-Pinanediol-CF3COOH,
(R)-3-METHYL-1-((3AS,4S,6S,7AR)-3A,5,5-TRIMETHYLHEXAHYDRO-4,6-METHANOBENZO[D][1,3,2]DIOXABOROL-2-YL)BUTAN-1-AMINE 2,2,2-TRIFLUOROACETATE,
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate,
(R)-BoroLeu-(+)-Pinanediol-CF3CO2H,
(R)-Boroleucine-(1S,2S,3R,5S)-(+)-pinanediol ester trifluoroacetate,
(1R)-(S)-Pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate,
AK-44948,
PubChem11602,
KS-00000LAX,
DTXSID00658025,
(1R)-(S)-Pinanediol 1-amino-3-methylbutane-1-boronate trifluoroacetate, 99%,
C15H28BNO2.C2HF3O2,
ACT03743,
ZX-RL003548,
MFCD10566030,
AKOS015896703,
AC-2355,
BS-2025,
CS-W019140,
RL02289,
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-, (alphaR,3aS,4S,6S,7aR)-, 2,2,2-trifluoroacetate (1:1),
AN-14069,
BC678968,
PC200351,
AB0009957,
AX8043663,
ST2414489,
(R)-BoroLeu-(+)-pinanediol-trifluoroacetate,
FT-0603990,
M-9817,
324P879,
I06-2263,
Q-102518,
(1R)-(S)-Pinanediol-1-ammoniumtrifluoroacetate-3-methylbutane-1-boronate,
(|AR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate,
(R)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate,
(|AR,3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-|A-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-Trifluoroacetate,
(1R)-1-[(1S,2S,6R,8S)-1,8-dihydrogenio-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]-3-methylbutan-1-amine; trifluoroacetic acid,
(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0?,?]decan-4-yl]butan-1-amine; trifluoroacetic acid,
(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0^{2,6}]decan-4-yl]butan-1-amine; trifluoroacetic acid,
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluor oacetate,
Trifluoroacetic acid--(1R)-3-methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-2H-4,6-methano-1,3,2-benzodioxaborol-2-yl]butan-1-amine (1/1),
Not Available,
Bortezomib intermediate,
SRFQKJZNJYTMNI-CDVUYJLHSA-N,
ACN-034364,
(1R)-(S)-Pinanediol 1-amino-3-methylbutane-1-boronate trifluoroacetate, 99% - 1G 1g,
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-meth ylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamin e 2,2,2-trifluoroacetate,